Precision For Medicine
Precision for Medicine is dedicated to solving complex clinical development challenges to bring innovative therapies to patients. They support and advance the work of their clients in changing lives through precision medicine, with a focus on oncology, rare diseases, autoimmune conditions, and more. Their integrated capabilities, deep scientific expertise, and responsive operations aim to accelerate research, reduce costs, and increase the probability of approval, ultimately bringing life-changing therapies to patients faster. The company also emphasizes a strong culture of service, philanthropy, and community engagement, supporting various nonprofit organizations and health initiatives worldwide.
Industries
Nr. of Employees
small (1-50)
Precision For Medicine
1234 Innovation Drive, Boston, MA, USA
Products
Translational informatics SaaS for biomarker and sample inventory management
Cloud-based platform for tracking clinical sample inventories, integrating biomarker and clinical data, and automating study reporting.
Biospecimen inventory and curated specimen panels
Cataloged and custom-curated biospecimen products including FFPE tissue blocks, PBMCs, leukopaks, plasma/serum units, swabs and matched longitudinal sets with clinical annotation.
Specimen panels and 510(k)-ready validation sets
Pre-configured specimen panels and validation cohorts tailored for diagnostic sensitivity/specificity testing and device study readiness.
Custom Tissue Microarrays (TMAs)
On-demand TMA production service including pathologist core selection, multiple core-size layouts and integrated slide sectioning and staining.
NGS-characterized biospecimen sets
NGS-profiled oncology specimen sets including FFPE blocks, isolated DNA/RNA and H&E images with associated variant and clinical metadata.
Ready-to-ship plasma and serum sample sets
Cataloged small-volume and bulk plasma/serum products with de-identified sample metadata and optional laboratory annotation for research, biomarker discovery and assay validation.
Translational informatics SaaS for biomarker and sample inventory management
Cloud-based platform for tracking clinical sample inventories, integrating biomarker and clinical data, and automating study reporting.
Biospecimen inventory and curated specimen panels
Cataloged and custom-curated biospecimen products including FFPE tissue blocks, PBMCs, leukopaks, plasma/serum units, swabs and matched longitudinal sets with clinical annotation.
Specimen panels and 510(k)-ready validation sets
Pre-configured specimen panels and validation cohorts tailored for diagnostic sensitivity/specificity testing and device study readiness.
Custom Tissue Microarrays (TMAs)
On-demand TMA production service including pathologist core selection, multiple core-size layouts and integrated slide sectioning and staining.
NGS-characterized biospecimen sets
NGS-profiled oncology specimen sets including FFPE blocks, isolated DNA/RNA and H&E images with associated variant and clinical metadata.
Ready-to-ship plasma and serum sample sets
Cataloged small-volume and bulk plasma/serum products with de-identified sample metadata and optional laboratory annotation for research, biomarker discovery and assay validation.
Services
Full-service clinical development support including feasibility, study start-up, monitoring, data management, medical monitoring, pharmacovigilance, biostatistics and medical writing.
Central lab testing, sample processing, PBMC isolation, bioanalysis, immune monitoring, flow cytometry, pathology, IHC and multiplex immunofluorescence across a global lab network.
Inventory and prospective collection of blood, plasma, serum, PBMCs, leukopaks, FFPE and fresh/frozen tissues with clinical annotation and optional multi-omic characterization.
SaaS solutions for biomarker data integration, sample inventory tracking and automated reporting to streamline translational workflows.
Kit manufacture, clinical site training, and end-to-end specimen shipment logistics with global shipping and biorepository interfaces.
Regulatory strategy and submission support for IVD and companion diagnostics, including CDx pathways for gene and cell therapies.
Full-service clinical development support including feasibility, study start-up, monitoring, data management, medical monitoring, pharmacovigilance, biostatistics and medical writing.
Central lab testing, sample processing, PBMC isolation, bioanalysis, immune monitoring, flow cytometry, pathology, IHC and multiplex immunofluorescence across a global lab network.
Inventory and prospective collection of blood, plasma, serum, PBMCs, leukopaks, FFPE and fresh/frozen tissues with clinical annotation and optional multi-omic characterization.
SaaS solutions for biomarker data integration, sample inventory tracking and automated reporting to streamline translational workflows.
Kit manufacture, clinical site training, and end-to-end specimen shipment logistics with global shipping and biorepository interfaces.
Regulatory strategy and submission support for IVD and companion diagnostics, including CDx pathways for gene and cell therapies.
Expertise Areas
- Clinical trial management and adaptive trial design
- Translational and biomarker sciences
- Biospecimen collection, prospective cohorts and biorepository management
- Central laboratory and specialty laboratory services
Key Technologies
- Next-generation sequencing (NGS) — targeted and exome panels
- Single-cell sequencing
- ddPCR and qPCR
- Spectral flow cytometry
News & Updates
Precision for Medicine is honored to be a finalist for the category of Innovative Solutions in Drug Development in the Fierce Biotech CRO Awards.
A detailed case study on global autologous cell therapy research.
An overview of modern adaptive strategies in phase 1 clinical trial design.
An article explaining the CRM approach in phase I trials.
An article explaining the BLRM approach in phase I trials.
Precision for Medicine is honored to be a finalist for the category of Innovative Solutions in Drug Development in the Fierce Biotech CRO Awards.
A detailed case study on global autologous cell therapy research.
An overview of modern adaptive strategies in phase 1 clinical trial design.
An article explaining the CRM approach in phase I trials.
An article explaining the BLRM approach in phase I trials.